A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

August 31, 2004

Conditions
Breast Cancer
Interventions
DRUG

ABT-751

Trial Locations (8)

33176

Oncology-Hematology Group of South Florida, Miami

33324

Clinical Research Network, Inc., Plantation

46202

Indiana University Cancer Center Section of of Hemtology/Oncology Indiana Cancer Pavilion, Indianapolis

60611

Northwestern University Medical School Division of Hematology/Oncology, Chicago

64111

Oncology & Hemotology Associates of Kansas City, PA, Kansas City

Unknown

Georgia Cancer Specialists, Atlanta

Northern Indiana Cancer Research Consortium, South Bend

Texas Oncology, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Abbott

INDUSTRY